These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. No risk, no ... cardioprotection? A critical perspective. Heusch G Cardiovasc Res; 2009 Nov; 84(2):173-5. PubMed ID: 19713282 [No Abstract] [Full Text] [Related]
26. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore. Mozaffari MS; Schaffer SW Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149 [TBL] [Abstract][Full Text] [Related]
28. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury. Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182 [TBL] [Abstract][Full Text] [Related]
29. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning. Skyschally A; Schulz R; Heusch G Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027 [TBL] [Abstract][Full Text] [Related]
30. Rediscovery of infarct imaging by cardiac CT. de Feyter PJ; Nieman K JACC Cardiovasc Imaging; 2009 Sep; 2(9):1082-4. PubMed ID: 19761986 [No Abstract] [Full Text] [Related]
31. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts. Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933 [TBL] [Abstract][Full Text] [Related]
32. Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial. Hallén J; Petzelbauer P; Schwitter J; Geudelin B; Buser P; Atar D EuroIntervention; 2010 Apr; 5(8):946-52. PubMed ID: 20542780 [TBL] [Abstract][Full Text] [Related]
33. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531 [TBL] [Abstract][Full Text] [Related]
34. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?]. Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337 [TBL] [Abstract][Full Text] [Related]